Retatrutide
Retatrutide (LY3437943) is an experimental molecule that activates GIP, GLP-1 and glucagon receptors and has been studied in metabolic research.
Select size
Quality guaranteed
Batch verified by independent HPLC
Research & handling
Use the product only within relevant laboratory procedures and institutional SOPs. Always review the current product label, CoA and SDS before use. Check packaging, labeling and batch information before use. Follow local procedures for storage, waste disposal and laboratory classification.
Suits well with
BAC WATER
3 ml · $5
Alcohol Wipes
10-pack · $4
Insulin Syringes
10-pack · $8
What is it?
Retatrutide is a so-called triple agonist that targets three hormonal signaling systems: GIP, GLP-1 and glucagon.
What is it researched for?
Retatrutide has been studied in areas including metabolic signaling, receptor biology, energy balance and glucose-related mechanisms.
Good to know
Retatrutide is an experimental research substance. Research findings should not be presented as a guarantee of human efficacy or safety.
Handling
Always follow the current product documentation, CoA, SDS and your laboratory's SOP. Check packaging and product documentation before use.
Specifications
- Product
- Retatrutide
- Amount
- 5 mg
- Research category
- Metabolic
- Research status
- Experimental research compound
- Batch
- #202681
- CoA
- SDS
- Documentation available on request
Documentation
Scientific sources
- Triple-Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial — PubMed
- LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes — PubMed
- Retatrutide (LY3437943) — literature search — PubMed
Links to public scientific literature. They describe research background only and are not evidence of medical effectiveness.
For research purposes only
Not intended for human or animal use.
Product information is provided for research and product-information purposes only and does not constitute medical advice.